Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Auteur de référence en rhumatologie
41 articles scientifiques publiés — un praticien à la pointe de la recherche
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
78.3 rhumatos / 100 000 hab. — département bien doté
3 publications sur 5 ans
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Influence scientifique
7
7 articles ont été cités au moins 7fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
257
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
17
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
6
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Université Paris-Saclay · Bicêtre Hospital
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Contribution of reed bed filter substrate’s microorganisms and vegetation to the biodegradation of road runoff organic micropollutants
2026ArticleJournal of Environmental Chemical Engineering
Long-term clinical and biological prognostic factors of anti-NMDA receptor encephalitis in children
2025ArticleNeurology Neuroimmunology & Neuroinflammation
Devenir des micropolluants dans un filtre planté de roseaux traitant les eaux de ruissellement de voirie – Importance des communautés microbiennes
2024Thèse
Devenir des micropolluants issus du trafic routier dans un filtre planté de roseaux dédié à la gestion des eaux de ruissellement - Importance de l'activité microbienne
2024Thèse
Spontaneously Resolving Encephalitis in Children with Acute COVID Infection
2023ArticleIndian Journal of Pediatrics
Accumulation of organic and metallic micropollutants over time and space in a Reed bed filter for urban runoff
2022Congrès17th International Conference on Wetland Systems for Water Pollution Control (ICWS)
Accumulation of organic and inorganic micropollutants over time and space in a constructed wetland for urban runoff
2022Congrès17th International Conference on Wetland Systems for Water Pollution Control (ICWS)
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CHI LE RAINCY MONTFERMEIL
10 R DU GENERAL LECLERC, 93370 MONTFERMEIL
CHI ANDRE GREGOIRE
56 BD DE LA BOISSIERE, 93100 MONTREUIL
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2001
Abstract Long-term treatment with glucocorticoids (GCs) leads to a rapid bone loss and to a greater risk of fractures. To evaluate the specific effects of this treatment on cancellous bone remodeling, structure, and microarchitecture, we compared 22 transiliac biopsy specimens taken in postmenopausal women (65 ± 6 years) receiving GCs (≥7.5 mg/day, for at least 6 months) and 22 biopsy specimens taken in age-matched women with postmenopausal osteoporosis (PMOP), all untreated and having either at least one vertebral fracture or a T score < −2.5 SD. On these biopsy specimens, we measured static and dynamic parameters reflecting trabecular bone formation and resorption. Also, we performed the strut analysis and evaluated the trabecular bone pattern factor (TBPf), Euler number/tissue volume (E/TV), interconnectivity index (ICI), and marrow star volume (MaSV). Glucocorticoid-induced osteoporosis (GIOP), when compared with PMOP, was characterized by lower bone volume (BV/TV), trabecular thickness (Tb.Th), wall thickness (W.Th), osteoid thickness (O.Th), bone formation rate/bone surface (BFR/BS), adjusted mineral apposition rate/bone surface (Aj.AR/BS), and higher ICI and resorption parameters. After adjustment for BV/TV, the W.Th remained significantly lower in GIOP (p < 0.0001). The active formation period [FP(a+)] was not different. Patients with GIOP were divided into two groups: high cumulative dose GCs (HGCs; 23.7 ± 9.7 g) and low cumulative dose GCs (LGCs; 2.7 ± 1.2 g). HGC when compared with LGC was characterized by lower W.Th (p < 0.05), BV/TV (p < 0.001), Tb.Th (p < 0.05), trabecular number (Tb.N; p < 0.05), FP(a+) (p < 0.05), and nodes (p < 0.05), and higher E/TV (p < 0.05), ICI (p < 0.005), and TBPf (p < 0.05). When HGC was compared with PMOP, the results were similar except for the MaSV, which was significantly higher (p < 0.005). In summary, GIOP was characterized by lower formation and higher resorption than in PMOP, already present after LGC. With HGCs, these changes were associated with a more dramatic bone loss caused by a major loss of trabecular connectivity.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019
ABSTRACT Sclerostin, a protein produced by osteocytes, inhibits bone formation. Administration of sclerostin antibody results in increased bone formation in multiple animal models. Romosozumab, a humanized sclerostin antibody, has a dual effect on bone, transiently increasing serum biochemical markers of bone formation and decreasing serum markers of bone resorption, leading to increased BMD and reduction in fracture risk in humans. We aimed to evaluate the effects of romosozumab on bone tissue. In a subset of 107 postmenopausal women with osteoporosis in the multicenter, international, randomized, double-blind, placebo-controlled Fracture Study in Postmenopausal Women with Osteoporosis (FRAME), transiliac bone biopsies were performed either after 2 (n = 34) or 12 (n = 73) months of treatment with 210 mg once monthly of romosozumab or placebo to evaluate histomorphometry and microcomputed tomography-based microarchitectural endpoints. After 2 months, compared with either baseline values assessed after a quadruple fluorochrome labeling or placebo, significant increases (P < 0.05 to P < 0.001) in dynamic parameters of formation (median MS/BS: romosozumab 1.51% and 5.64%; placebo 1.60% and 2.31% at baseline and month 2, respectively) were associated with a significant decrease compared with placebo in parameters of resorption in cancellous (median ES/BS: placebo 3.4%, romosozumab 1.8%; P = 0.022) and endocortical (median ES/BS: placebo 6.3%, romosozumab 1.6%; P = 0.003) bone. At 12 months, cancellous bone formation was significantly lower (P < 0.05 to P < 0.001) in romosozumab versus placebo and the lower values for resorption endpoints seen at month 2 persisted (P < 0.001), signaling a decrease in bone turnover (P = 0.006). No significant change was observed in periosteal and endocortical bone. This resulted in an increase in bone mass and trabecular thickness with improved trabecular connectivity, without significant modification of cortical porosity at month 12. In conclusion, romosozumab produced an early and transient increase in bone formation, but a persistent decrease in bone resorption. Antiresorptive action eventually resulted in decreased bone turnover. This effect resulted in significant increases in bone mass and improved microarchitecture.© 2019 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research (ASBMR).
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Cells · 2026 · Journal Article
Samee N, Belz L, Narboux-Nême N, Roux JC, et al.
Journal of science and medicine in sport · 2025 · Journal Article
Le Roux J, Janse van Rensburg DC, Kemp S, Lambert M, et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024 · Journal Article
Chavassieux P, Roux JP, Libanati C, Shi Y, et al.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024 · Journal Article
Roux JP, Duboeuf F, Sornay-Rendu E, Rinaudo L, et al.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024 · Journal Article
Chavassieux P, Roux JP, Chapurlat R
Clinics and research in hepatology and gastroenterology · 2024 · Journal Article
Thabut D, Roux J, Sultanik P, Tamberou C, et al.
Bone · 2022 · Journal Article
Borggaard XG, Roux JP, Delaisse JM, Chavassieux P, et al.
Hand surgery & rehabilitation · 2021 · Journal Article
Roux JL
Bone · 2021 · Journal Article
Jensen PR, Andersen TL, Chavassieux P, Roux JP, et al.
Bone reports · 2020 · Journal Article
Roux JP, Boutroy S, Bouxsein ML, Chapurlat R, et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019 · Journal Article
Chavassieux P, Chapurlat R, Portero-Muzy N, Roux JP, et al.
Acta oncologica (Stockholm, Sweden) · 2016 · Journal Article
Sebbagh S, Roux J, Dreyer C, Neuzillet C, et al.
Bone · 2015 · Journal Article
Pereira M, Jeyabalan J, Jørgensen CS, Hopkinson M, et al.
Frontiers in immunology · 2015 · Journal Article
Osta B, Roux JP, Lavocat F, Pierre M, et al.
Bone · 2011 · Comparative Study
Boutroy S, Vilayphiou N, Roux JP, Delmas PD, et al.
Chirurgie de la main · 2010 · English Abstract
Roux JL
Arthritis care & research · 2010 · Comparative Study
Gensburger D, Roux JP, Arlot M, Sornay-Rendu E, et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2010 · Journal Article
Wegrzyn J, Roux JP, Arlot ME, Boutroy S, et al.
Arthritis and rheumatism · 2009 · Journal Article
Gensburger D, Arlot M, Sornay-Rendu E, Roux JP, et al.
Calcified tissue international · 2005 · Evaluation Study
Portero NR, Arlot ME, Roux JP, Duboeuf F, et al.
Chirurgie de la main · 2004 · English Abstract
Roux JL
Revue medicale de la Suisse romande · 2004 · Comparative Study
Arlot M, Roux JP, Portero N, Boivin G, et al.
Revue medicale de la Suisse romande · 2004 · English Abstract
Roux JP, Follet H, Arlot ME, Merabet Z, et al.
Chirurgie de la main · 2003 · English Abstract
Roux JL
Annales de chirurgie de la main et du membre superieur : organe officiel des societes de chirurgie de la main = Annals of hand and upper limb surgery · 1996 · Case Reports
Roux JL, Mouzayek H, Allieu Y
Bone · 1995 · Journal Article
Roux JP, Arlot ME, Gineyts E, Meunier PJ, et al.
Arthritis and rheumatism · 1994 · Journal Article
Miossec P, Chomarat P, Dechanet J, Moreau JF, et al.
Calcified tissue international · 1993 · Journal Article
Arlot ME, Bradbeer JN, Edouard C, Green JR, et al.
Journal of neurology, neurosurgery, and psychiatry · 2025 · Journal Article
El Hajj A, Ruiz A, Gavoille A, Couturier J, et al.
Neurology(R) neuroimmunology & neuroinflammation · 2025 · Journal Article
Mazowiecki M, Flet-Berliac L, Roux J, Lépine A, et al.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie · 2025 · Journal Article
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2001 · Comparative Study
Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2000 · Clinical Trial
Chavassieux PM, Arlot ME, Roux JP, Portero N, et al.
JBMR plus · 2026 · Journal Article
Dahl XG, Roux JP, Delaisse JM, Huang S, et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019 · Comparative Study
Chavassieux P, Portero-Muzy N, Roux JP, Horlait S, et al.
Neurosurgical focus · 2025 · Journal Article
Guida L, Gardin A, James S, Arnaud E, et al.
Multiple sclerosis journal - experimental, translational and clinical · 2020 · Journal Article
Guilleux A, Roux J, Travers D, Leray E
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2014 · Clinical Trial, Phase III
Chavassieux P, Meunier PJ, Roux JP, Portero-Muzy N, et al.
BMJ open sport & exercise medicine · 2023 · Journal Article
Le Roux J, Anema F, Janse van Rensburg DC, Kerkhoffs G, et al.
Case reports in medicine · 2009 · Case Reports
Toffart AC, Arbib F, Lantuejoul S, Roux JF, et al.
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
Roux J, Bommier-Laur D, Calota M, Auvin S, et al.
Neurosurgical focus · 2025 · Journal Article
Guida L, Gardin A, James S, Arnaud E, et al.
Indian journal of pediatrics · 2023 · Letter
Casabianca M, Roux J, Auvin S, Titomanlio L, et al.